Study reveals molecular mechanism linking statins to muscle side effects via NLRP3 inflammasome and protein-prenylation pathway

Jonathan D. Schertzer

10h ago· 48 min readenInsight

science health medical research pharmacology

Summary

This scientific research article investigates the molecular mechanisms behind statin-associated myopathy (muscle side effects). The study finds that statins promote muscle metabolic dysfunction and inflammation through the NLRP3 inflammasome pathway, mediated by reduced protein-prenylation and YAP signaling. The research explains why statin-intolerant patients experience muscle pain and damage, and identifies potential therapeutic targets to mitigate these side effects while preserving the cardiovascular benefits of statins.

Source

Twitter / XStudy reveals molecular mechanism linking statins to muscle side effects via NLRP3 inflammasome and protein-prenylation pathwayscience.org

Key quotes

· 4 pulled

Statins are widely prescribed because this class of drugs reduces cardiovascular events and all-cause mortality.

Millions of people suffer from statin side effects, but the only recourse is to reduce the statin dose or discontinue use.

This 'statin-intolerance' compromises the effectiveness of this drug class as side effects often limit the statin dose needed to lower blood cholesterol to levels that maximize reduced cardiovascular disease risk.

Statins have pleiotropic effects beyond cholesterol lowering, which can be beneficial or lead to side effects.

Snippet from the RSS feed

Statin intolerance and side effects such as low-level myopathy limit statin use and the dose for optimal cholesterol lowering. We found that priming the NLRP3 inflammasome with bacterial components...

You might also wanna read

Mitochondria-derived vesicles with bioenergetic units from brown adipose tissue attenuate cardiac remodeling post-myocardial infarction

doi.org·1d ago

αKG-mediated carnitine synthesis drives DNA repair via histone acetylation | Nature

doi.org·25d ago

Mouse Study Links Protein TTP to Improved Strength and Reduced Frailty in Aging

Researchers at the University at Buffalo identified the protein tristetraprolin (TTP) as a potential target for reducing age-related frailty

sciencealert.com·17d ago

C2orf74 orchestrates germ-Leydig crosstalk to inhibit white adipose tissue browning in male mice